The infiltration of multifunctional (IFN-γ+GzmB+) CD8+ T cells, which have previously been shown to be cytolytic (29), into tumor was also greatly increased following PRGN-2009 treatment (48.4%) compared with PBS control (0%) (Figure 3D). The gene discussed is CD8A; the disease is neoplasm.